Acute respiratory infections place a huge burden on society in terms of disability, premature mortality, and also direct health service costs (drugs prescriptions) and the indirect costs related to lost production. Therefore, prevention of respiratory infections is an important goal for public health interventions. In this context, silver nanoparticles (AgNPs) represent an interesting perspective for research and development by virtue of their favorable antimicrobial activity against many respiratory pathogens. One of the latest innovations in the biotech field discussed in this review is the creation of a biocompatible, biogel-based nasal filter enriched with AgNPs. Compared to traditional personal protective equipment (PPE), this type of nasal filter has the advantage of combining the antibacterial and antiviral activity of AgNPs with the common filtration capacity shared by other PPEs. This dual mechanism means that AgNP-enriched nasal filters serve to reduce the infecting microbial-load and protect the lower airways, without interfering with the normal respiratory capacity (airflow-resistance <5%). Given their antimicrobial characteristics and performance, AgNP-enriched nasal filters can meet many community and occupational currently unmet needs in the prevention of airborne infectious diseases, by ensuring an excellent respiratory-comfort and a continuous day-use.

Biotech innovations in the prevention of respiratory infectious diseases / J.V. Cento, S. Barbaliscia, C.F. Perno. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 40:3(2017 Jul), pp. 155-160.

Biotech innovations in the prevention of respiratory infectious diseases

C.F. Perno
2017

Abstract

Acute respiratory infections place a huge burden on society in terms of disability, premature mortality, and also direct health service costs (drugs prescriptions) and the indirect costs related to lost production. Therefore, prevention of respiratory infections is an important goal for public health interventions. In this context, silver nanoparticles (AgNPs) represent an interesting perspective for research and development by virtue of their favorable antimicrobial activity against many respiratory pathogens. One of the latest innovations in the biotech field discussed in this review is the creation of a biocompatible, biogel-based nasal filter enriched with AgNPs. Compared to traditional personal protective equipment (PPE), this type of nasal filter has the advantage of combining the antibacterial and antiviral activity of AgNPs with the common filtration capacity shared by other PPEs. This dual mechanism means that AgNP-enriched nasal filters serve to reduce the infecting microbial-load and protect the lower airways, without interfering with the normal respiratory capacity (airflow-resistance <5%). Given their antimicrobial characteristics and performance, AgNP-enriched nasal filters can meet many community and occupational currently unmet needs in the prevention of airborne infectious diseases, by ensuring an excellent respiratory-comfort and a continuous day-use.
No
English
airways protection; disease prevention; nasal filter; personal protective equipment; respiratory infections; silver nanoparticles; biotechnology; community-acquired infections; cost of illness; cross infection; filtration; gels; humans; metal nanoparticles; occupational diseases; personal protective equipment; respiratory tract infections; silver
Settore MED/07 - Microbiologia e Microbiologia Clinica
Articolo
Esperti anonimi
Pubblicazione scientifica
lug-2017
EDIMES
40
3
155
160
6
Pubblicato
Periodico con rilevanza internazionale
Aderisco
info:eu-repo/semantics/article
Biotech innovations in the prevention of respiratory infectious diseases / J.V. Cento, S. Barbaliscia, C.F. Perno. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 40:3(2017 Jul), pp. 155-160.
reserved
Prodotti della ricerca::01 - Articolo su periodico
3
262
Article (author)
si
J.V. Cento, S. Barbaliscia, C.F. Perno
File in questo prodotto:
File Dimensione Formato  
2017_Biotech innovations in the prevention of respiratory infectious diseases_newmicrob.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 723.04 kB
Formato Adobe PDF
723.04 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/558809
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 6
social impact